Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 685-281-3 | CAS number: 2624-17-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Short description of key information on bioaccumulation potential result:
Read-across from studies conducted on cyanuric acid and experimental results on sodium cyanurate monohydrate.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
Additional information
Experimental results obtained in two studies with the substance monosodium salt of cyanuric acid, monohydrate there is no evidence for bioaccumulation of the compound and there are no major changes in the disposition or metabolism of sodium cyanurate following repeated administration.
Based on the experimental results obtained in 5 studies with the analogue cyanuric acid (data on cumulative excretion curves, absorption, excretion in human and data on distribution and absorption of radiolabelled cyanuric acid in rats) and the molecular weights, the read-across approach is applied and the same results can be extrapolated for sodium cyanurate.
Discussion on bioaccumulation potential result:
1. Based on the experimental results obtained with the substance monosodium salt of cyanuric acid, monohydrate there is no evidence for bioaccumulation of the compound and there are no major changes in the disposition or metabolism of sodium cyanurate following repeated administration.
Read-across: 2. Based on the experimental results obtained with the analogue cyanuric acid (the cumulative excretion curves gave a mean elimination half life of 2.2 h. Analysis of the data by excretion rate gives an elimination half life of 3.5 h with an average A value of 3.4 mg/h. The average observed recovery of cyanuric acid after 20 h is 9.8 mg, whereas the value by curve fitting is 11.5 mg (this probably reflected both skin absorption and oral intake). When 5 volunteers soaked in a swimming pool for 120 min, recovery was 0.03-2.8 mg cyanuric acid (this probably reflected skin absorption only). Cyanuric acid is excreted rapidly, with a half life of approximately 3 h.) the read-across approach is applied and the same results can be extrapolated for substance sodium cyanurate.
3. Based on the experimental results obtained with the analogue cyanuric acid (Orally ingested cyanuric acid appears to be totally excreted unchanged in urine within 24 hours, with t ½ ~1 h. In swimmers, the uptake is largely oral, rates of dermal uptake during immersion (presumably without swimming) being considerably lower. Cyanurate is completely absorbed and excreted unchanged following oral ingestion. When swimming, uptake is largely by oral ingestion) the read-across approach is applied and the same results can be extrapolated for substance sodium cyanurate.
4. Based on the experimental results obtained with the analogue cyanuric acid (14C-Isocyanuric acid, given orally to rats, distributed rapidly, showing highest radioactivity concentrations in blood, liver and kidney. Maximum concentrations occurred 0.5 h after dosing. Thereafter radioactivity decreased rapidly, with half lives of approximately 1 h. The radioactivity was excreted almost entirely in urine as unchanged substance. When administered dermally, very little radiolabelled isocyanurate was taken up) the read-across approach is applied and the same results can be extrapolated for substance sodium cyanurate.
5. Based on the experimental results obtained with the analogue cyanuric acid (An in vitro model system indicates that cyanurate is poorly absorbed through the skin in all the species tested) the read-across approach is applied and the same results can be extrapolated for substance sodium cyanurate.
6. Based on the experimental results obtained with the analogue cyanuric acid (young competitive, long-distance swimmers swallowed 3.5 times more water (126 mL) than young recreational swimmers (37 mL) the read-across approach is applied and the same results can be extrapolated for substance sodium cyanurate.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.